rss – PRAIS 2.0

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

Murilo Freitas - 16:24, 22 de December de 20249

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
http://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-once-daily-glp-1-injection-lower-blood-sugar-patients-type-2-diabetes

rss

Alcon Laboratories Issues Voluntary Nationwide Recall of One (1) Lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101), Due to Fungal Contamination

Murilo Freitas - 05:00, 22 de December de 202412

Fort Worth, Texas. Alcon Laboratories is voluntarily recalling one (1) lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101) to the consumer level. Alcon evaluated a consumer complaint of foreign material observed inside a sealed single use vial and determined th

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/alcon-laboratories-issues-voluntary-nationwide-recall-one-1-lot-systane-lubricant-eye-drops-ultra-pf

rss rss-es rss-pt

Early Alert: Endoscope Accessories Forceps/Irrigation Plug Issue from Olympus

Murilo Freitas - 05:00, 22 de December de 202411

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program

http://www.fda.gov/medical-devices/medical-device-recalls/early-alert-endoscope-accessories-forcepsirrigation-plug-issue-olympus

rss

FDA Approves First Medication for Obstructive Sleep Apnea

Murilo Freitas - 22:03, 19 de December de 202418

FDA Approves First Medication for Obstructive Sleep Apnea
http://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea

rss

FDA Roundup: December 20, 2024

Murilo Freitas - 19:28, 19 de December de 202426

FDA Roundup: December 20, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-20-2024

rss

FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities

Murilo Freitas - 14:25, 19 de December de 202421

FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities
http://www.fda.gov/news-events/press-announcements/fda-approves-first-acellular-tissue-engineered-vessel-treat-vascular-trauma-extremities

rss

Early Alert: Nephroscope Sheath Issue from Trokamed GmbH

Murilo Freitas - 05:00, 19 de December de 202423

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program

http://www.fda.gov/medical-devices/medical-device-recalls/early-alert-nephroscope-sheath-issue-trokamed-gmbh

rss

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Murilo Freitas - 05:00, 19 de December de 202431

Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of Adrenalin® Chloride Solution (EPINEPHrine nasal solution, USP) 30mg/30mL (1mg/mL) 30 mL vials, to the consumer level. This product, which pre-d

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/endo-usa-inc-issues-voluntary-nationwide-recall-adrenalinr-chloride-solution-epinephrine-nasal

rss

FDA Updates “Healthy” Claim, Providing a Refreshed Tool for Consumers

Murilo Freitas - 16:39, 18 de December de 202426

FDA Updates “Healthy” Claim, Providing a Refreshed Tool for Consumers
http://www.fda.gov/news-events/press-announcements/fda-updates-healthy-claim-providing-refreshed-tool-consumers

rss

FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease

Murilo Freitas - 21:40, 17 de December de 202445

FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease
http://www.fda.gov/news-events/press-announcements/fda-approves-first-mesenchymal-stromal-cell-therapy-treat-steroid-refractory-acute-graft-versus-host